Biotechnology News » and-marketing

3SBio ties up with Ascentage Pharma to develop & commercialize cancer therapeutics (PharmaBiz)

admin — Mon, 15 Feb 2010 05:36:25 +0000

3SBio Inc, a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, and Ascentage Pharma Group Corporation, Ltd have formed a strategic alliance to research, develop and commercialize best-in-class targeted cancer therapeutics focusing on programmed cell death, or apoptosis.

Read the original post:
3SBio ties up with Ascentage Pharma to develop & commercialize cancer therapeutics (PharmaBiz)

3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience (News-Medical-Net)

admin — Mon, 08 Feb 2010 11:46:41 +0000

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.

Market Media Connect retained as Northwest Biotherapeutics’ communications agency of record (News-Medical-Net)

admin — Mon, 08 Feb 2010 10:16:37 +0000

Northwest Biotherapeutics, Inc., a development stage biotechnology company focused on personalized cancer vaccines to enhance immune system responses to tumors, has retained Market Media Connect as their communications agency of record. Led from its Los Angeles headquarters, Market Media Connect will support Northwest’s communication objectives as the company moves into the next phase of its …